cancer drugs

Ono to Acquire Deciphera for $2.4 Billion

Japan’s Ono Pharmaceutical agreed to acquire US cancer-therapy company Deciphera Pharmaceuticals for approximately $2.4 billion. Deciphera focuses on innovative cancer therapeutics, and specializes in kinase biology.

EU Commission Approves Pfizer’s Takeover of Seagen

The US pharmaceutical company Pfizer has been cleared to acquire Seagen, a biotech company focused on developing cancer treatments.

EU Investigates Aspen for Price Gouging

AstraZeneca Cancer Drug Breakthrough

New Immunotherapy Coalition Launched in US

AstraZeneca Confirms Talks with Acerta

Merck Serono in Spanish Drug Development Pact

Roche to Spend $880 Million on Manufacturing, Create 500 Jobs

Astrazeneca CEO Gets Two Cheers after First Year in Job

Infinity Pharma's Cancer Drug Fails Mid-Stage Trial Goals

Roche Suffers Diabetes Drug Setback

Tamiflu And Cancer Drugs Lift Roche Above Forecasts

India Rules Against Bayer in Cancer Drug Patent Case

More Pressure to Justify Cost of Cancer Drugs Versus Benefits

Roche Sees More Cancer Success as Sales Top Forecast

Laurantis Pharma, Ark Therapeutics Sign Manufacturing Agreement

Roche Takes $1.7 Billion Charges as it Confirms Outlook

China Changes Patent Law in Fight for Cheaper Drugs

Merck KGaA, Dr. Reddy's in Biosimilars Deal

Roche Q1 Sales Flat as Illumina Bid Battle Rages

Chasing Cheaper Cancer Drugs

Roche Extends Illumina Bid Again